Intra-Arterial Tissue Plasminogen Activator for Central Retinal Artery Occlusion
Ethan K Sobol,1,2 Yu Sakai,3 Danielle Wheelwright,3 Carl S Wilkins,1,2 Amanda Norchi,1 Michael G Fara,4 Christopher Kellner,3 James Chelnis,1 J Mocco,3 Richard B Rosen,1,2 Reade A De Leacy,3 Gareth MC Lema1,2 1Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029,...
Guardado en:
Autores principales: | Sobol EK, Sakai Y, Wheelwright D, Wilkins CS, Norchi A, Fara MG, Kellner C, Chelnis J, Mocco J, Rosen RB, De Leacy RA, Lema GMC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/45d940185dcb4e41b4535cf9257d49dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hyperbaric Oxygen Therapy for Central Retinal Artery Occlusion: Patient Selection and Perspectives
por: Celebi ARC
Publicado: (2021) -
Reversibility of retinal ischemia due to central retinal artery occlusion by hyperbaric oxygen
por: Hadanny A, et al.
Publicado: (2016) -
Simultaneous environmental manipulations in semi-perfusion cultures of CHO cells producing rh-tPA
por: Vergara,Mauricio, et al.
Publicado: (2012) -
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White DE, et al.
Publicado: (2019) -
Customized anterior segment photoacoustic imaging for ophthalmic burn evaluation in vivo
por: Huangxuan Zhao, et al.
Publicado: (2021)